check quantity

IntegriSense 750 Fluorescent Imaging Agent

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications. 

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Product Number List Price Your Price Quantity
NEV10873 663.00 USD

You successfully added item(s) to your cart

Overview

IntegriSense™ 750 is a targeted fluorescent imaging agent comprising a potent, selective non-peptide small molecule integrin avb3 antagonist and a near- infrared (NIR) fluorochrome. IntegriSense 750 has a shorter half life in tissue than IntegriSense 680. IntegriSense 750 washes out of tissues in ~ 96 hours to permit more frequent reinjection of the agent in longitudinal studies. This agent has been developed to enable in vivo visualization and quantification of integrin avb3 in tumor cells as well as in neovasculature, to monitor tumor growth, tumor angiogenesis, and treatment efficacy. Absorbance and fluorescence emission spectra of IntegriSense 750 in 1x PBS.

Disclaimer: For laboratory use only. This product is intended for animal research only and not for use in humans.

Specifications

Fluorescent Agent Type Targeted
Optical Imaging Classification Fluorescence Imaging
Product Brand Name IntegriSense
Shipping Condition Blue Ice
Therapeutic Area Atherosclerosis, Oncology/Cancer, Angiogenesis
Unit Size 1 Vial (10 doses)
Wave Length 750 nm

Tools

Resources, Events & More

All (6)
Resource Type File Name File Format
Brochure In Vivo Imaging Agents Brochure PDF 2 MB
Application Note In Vivo Imaging of Atherosclerosis Disease Using FMT PDF 1 MB
Application Note Multiplex 2D Imaging of NIR Molecular Imaging Agents on the IVIS SpectrumCT and FMT 4000 PDF 4 MB
Technical Note IntegriSense 750 (Protocol) PDF 258 KB
Technical Note IntegriSense™ 750 (Data Sheet) PDF 57 KB
Citations Library View peer reviewed publications using PerkinElmer's In Vivo Imaging Reagents Link